Kestra Medical Operating Income Over Time
| KMTS Stock | 26.92 0.54 1.97% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Kestra Medical Performance and Kestra Medical Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Kestra introduce new products? Factors like these will boost the valuation of Kestra Medical. Expected growth trajectory for Kestra significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Kestra Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.96) | Revenue Per Share | Quarterly Revenue Growth 0.534 | Return On Assets | Return On Equity |
The market value of Kestra Medical Techn is measured differently than its book value, which is the value of Kestra that is recorded on the company's balance sheet. Investors also form their own opinion of Kestra Medical's value that differs from its market value or its book value, called intrinsic value, which is Kestra Medical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Kestra Medical's market value can be influenced by many factors that don't directly affect Kestra Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Kestra Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Kestra Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Kestra Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Kestra Medical Techn and related stocks such as Azenta Inc, Novocure, and STAAR Surgical Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AZTA | 2.5 M | 21.5 M | (8.5 M) | 4 M | 22.3 M | 19.5 M | 18.2 M | 34.4 M | 55.1 M | (27.5 M) | 3.6 M | (24 M) | (82.2 M) | (30 M) | (11.3 M) | (13 M) | (13.6 M) |
| NVCR | (64.5 M) | (64.5 M) | (64.5 M) | (64.5 M) | (80.2 M) | (104 M) | (115.3 M) | (39.3 M) | (33.7 M) | (914 K) | 30.4 M | (44.3 M) | (89.5 M) | (232.9 M) | (170.5 M) | (153.4 M) | (145.8 M) |
| STAA | (2.7 M) | 2.8 M | (1.2 M) | 700 K | (8 M) | (5.3 M) | (12.7 M) | (3.6 M) | 6.6 M | 11.9 M | 6.8 M | 33.3 M | 43.8 M | 28.1 M | (12.6 M) | (14.5 M) | (13.8 M) |
| BLFS | (300 K) | (1.2 M) | (942.2 K) | (285.4 K) | (3.1 M) | (5 M) | (4.9 M) | (1.1 M) | 3.7 M | (781 K) | (3.3 M) | (35.2 M) | (5.9 M) | (70.8 M) | (7.1 M) | (6.4 M) | (6.7 M) |
| WVE | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (5.4 M) | (19.3 M) | (55.3 M) | (102.6 M) | (159.5 M) | (208.3 M) | (153.4 M) | (127 M) | (162.7 M) | (68 M) | (110.4 M) | (99.4 M) | (104.3 M) |
| PLSE | (308.6 K) | (308.6 K) | (308.6 K) | (308.6 K) | (308.6 K) | (4.5 M) | (9.6 M) | (25.8 M) | (38 M) | (48 M) | (50 M) | (63 M) | (58.1 M) | (43.6 M) | (56.3 M) | (50.6 M) | (53.2 M) |
| NEOG | (800 K) | 33.7 M | 40.7 M | 43.4 M | 53.1 M | 56.4 M | 64.9 M | 70.2 M | 68.1 M | 67.5 M | 74.2 M | 58.6 M | 37.5 M | 77.4 M | 9.4 M | 10.8 M | 10.3 M |
| TERN | (18.5 M) | (18.5 M) | (18.5 M) | (18.5 M) | (18.5 M) | (18.5 M) | (18.5 M) | (18.5 M) | (18.5 M) | (70.2 M) | (37 M) | (49.9 M) | (62 M) | (102.6 M) | (101.9 M) | (91.7 M) | (96.3 M) |
| PGEN | (82.4 M) | (82.4 M) | (75.2 M) | (58 M) | (70 M) | (146.9 M) | (125.2 M) | (137.9 M) | (505.6 M) | (86.3 M) | (86.3 M) | (91.9 M) | (75.7 M) | (99.8 M) | (135 M) | (121.5 M) | (127.6 M) |
| EVO | (12.7 M) | 5.2 M | (3.2 M) | (21.4 M) | (6.4 M) | 11.6 M | 31.3 M | 37.5 M | 77.5 M | 62.6 M | 48.6 M | 41 M | 20.9 M | (107.1 M) | (142.5 M) | (163.9 M) | (155.7 M) |
Kestra Medical Techn and related stocks such as Azenta Inc, Novocure, and STAAR Surgical Operating Income description
Operating Income is the amount of profit realized from Kestra Medical Techn operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Kestra Medical Technologies is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Kestra Medical Technologies | KMTS |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 3933 Lake Washington |
| Exchange | NASDAQ Exchange |
null 26.92
Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.